Data Asset Self-Reporting in Pharma

This paper was co-written by BYU, ZONTAL, Agilent, and Bristol Myers Squibb with input from multiple other large Pharma companies. It explores the need for contextualizing data to create self-reporting data assets. Further, it compares different technologies that are available for reaching the goal of FAIR data in the laboratory. Get free access to the full article below!